Necroptosis in inflammatory bowel disease and other intestinal diseases

被引:0
|
作者
Sha Li [1 ]
Long-Gui Ning [1 ]
Xin-He Lou [1 ]
Guo-Qiang Xu [2 ]
机构
[1] Department of Gastroenterology, the First Affiliated Hospital, College of Medicine,Zhejiang University
[2] Department of Gastroenterology,the First Affiliated Hospital, College of Medicine, Zhejiang University
关键词
Inflammatory bowel disease; Necroptosis; Inflammation; Colorectal cancer; Intestinal infectious diseases; Drug therapy; Receptor interacting protein kinase 1 inhibitor;
D O I
暂无
中图分类号
R574 [肠疾病];
学科分类号
1002 ; 100201 ;
摘要
For a long time, it was believed that apoptosis and necrosis were the main pathways for cell death, but a growing body of research has shown that there are other pathways. Among these, necroptosis, a regulatory caspase-independent, programmed cell death pathway, is supposed to be of importance in the pathogenesis of many diseases. The mechanism of regulating, inducing and blocking necroptosis is a complex process that involves expression and regulation of a series of molecules including receptor interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase like protein. By blocking or downregulating expression of key molecules in the necroptotic pathway, intestinal inflammation can be affected to some extent. In this paper, we introduce the concept of necroptosis, its main pathway, and its impact on the pathogenesis of inflammatory bowel disease(IBD) and other intestinal diseases, to explore new drug targets for intestinal diseases, including IBD.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [31] Intestinal ultrasound in inflammatory bowel disease
    Asthana, Anil Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 21 - 22
  • [32] The Intestinal Microbiota in Inflammatory Bowel Disease
    Becker, Christoph
    Neurath, Markus F.
    Wirtz, Stefan
    ILAR JOURNAL, 2015, 56 (02) : 192 - 204
  • [33] The intestinal epithelium and inflammatory bowel disease
    Podolsky, DK
    Gut-Liver Interactions: Basic and Clinical Concepts, 2006, 146 : 46 - 50
  • [34] Intestinal Transplant for Inflammatory Bowel Disease
    Garcia, J.
    Farag, A.
    Selvaggi, G.
    Tekin, A.
    dos Santos, Miyashiro Nunes R.
    Venkatasamy, V.
    Tector, J.
    Ruiz, P.
    Vianna, R.
    TRANSPLANTATION, 2021, 105 (7S) : S77 - S77
  • [35] Intestinal microbiome and inflammatory bowel disease
    Schwerd, T.
    Koletzko, S.
    MONATSSCHRIFT KINDERHEILKUNDE, 2019, 167 (05) : 420 - 425
  • [36] Intestinal dysbiosis in inflammatory bowel disease
    Kaur, Nirmal
    Chen, Chun-Chia
    Luther, Jay
    Kao, John Y.
    GUT MICROBES, 2011, 2 (04) : 211 - 216
  • [37] Intestinal barrier in inflammatory bowel disease
    Antoni, Lena
    Nuding, Sabine
    Wehkamp, Jan
    Stange, Eduard F.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (05) : 1165 - 1179
  • [38] Intestinal bacteria and inflammatory bowel disease
    Macfarlane, Sandra
    Steed, Helen
    Macfarlane, George T.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2009, 46 (01) : 25 - 54
  • [39] The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study
    Bernstein, CN
    Wajda, A
    Blanchard, JF
    GASTROENTEROLOGY, 2005, 129 (03) : 827 - 836
  • [40] Association of paediatric inflammatory bowel disease with other immune-mediated diseases
    Kappelman, Michael D.
    Galanko, Joseph A.
    Porter, Carol Q.
    Sandler, Robert S.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2011, 96 (11) : 1042 - 1046